Steven Mizell

Steven Mizell (senior executive) discloses dealings in 5 companies, chiefly Allegion plc, Merck & Co., Inc. and GRAIL, Inc. The record holds 45 filings, for trades running from 2 February 2016 to 15 October 2026.

Market trades split into 2 purchases (€149k) and 7 sales (€2.2M). Netting one side against the other leaves €2.1M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 31 share grants and 5 option exercises. In 2026 alone, the filings show 1 purchase and 1 sale.

Most recently, on 16 October 2026, the filings show a share grant worth €18k in GRAIL, Inc. The clock since the last published purchase (31 August 2026) now reads 48 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.